A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling ...

A Senate committee voted to hold Ralph de la Torre, CEO of troubled Steward Health Care, in contempt. If the full Senate ...

As for Amazon, it’s staying true to it’s legacy as an online store. Invitations described the event as an opportunity to ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.

Twice-a-year-PReP will only fulfill its potential if Medicaid takes decisive action to ensure it is accessible to the ...

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

Why Corbus Pharmaceuticals sees Novo Nordisk’s controversial approach to obesity drugs as a ticket to a blockbuster.

Vonda Vaden Bates’ husband “might have survived if we had not confused kindness with skilled, quality care,” she writes.

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...